Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,642.00 ILa | -0.96% |
|
-2.01% | -4.44% |
| 07-09 | Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus | MT |
| 07-09 | Teva, Samsung Bioepis Partner to Commercialize Eylea Biosimilar Opuviz in Canada | MT |
| Market Cap | 37.3B 0 32.69B 30.22B 27.79B 52.44B 3,597B 53.28B 361B 142B 1,760B 140B 137B 6,063B | P/E 2026 * |
39.5x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 48.48B 0 42.49B 39.28B 36.12B 68.16B 4,675B 69.25B 470B 184B 2,287B 182B 178B 7,881B | EV / Sales 2026 * |
2.91x | EV / Sales 2027 * | 2.65x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | -0.96% | ||
| 1 week | -2.01% | ||
| Current month | -1.98% | ||
| 1 month | +2.80% | ||
| 3 months | -0.17% | ||
| 6 months | -3.21% | ||
| Current year | -4.44% |
| 1 week | 9,460 |  | 9,930 |
| 1 month | 9,277 | | 10,730 |
| Current year | 8,860 | | 11,350 |
| 1 year | 5,305 | | 11,350 |
| 3 years | 3,002 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 21,320 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | -2.01% | - | - | 37.3B | |
| -1.64% | -1.53% | +52.69% | +150.91% | 1,051B | |
| -1.27% | -3.07% | +52.02% | +48.39% | 609B | |
| -0.51% | +2.17% | +37.07% | +78.20% | 450B | |
| -0.75% | +0.30% | +29.77% | +21.15% | 330B | |
| -1.52% | -1.19% | +34.46% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.99% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.18% | -40.59% | 223B | |
| -0.26% | +1.52% | +23.68% | +56.90% | 198B | |
| -0.65% | +1.86% | +23.61% | +67.44% | 167B | |
| Average | -0.96% | +0.54% | +28.24% | +48.16% | 397.23B | |
| Weighted average by Cap. | -1.15% | +0.02% | +37.20% | +72.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.64B 0 14.59B 13.48B 12.4B 23.4B 1,605B 23.78B 161B 63.21B 785B 62.5B 61.13B 2,706B | 17.24B 0 15.11B 13.97B 12.85B 24.24B 1,662B 24.63B 167B 65.47B 813B 64.74B 63.32B 2,803B |
| Net income | 1.31B 0 1.15B 1.06B 976M 1.84B 126B 1.87B 12.68B 4.97B 61.77B 4.92B 4.81B 213B | 2.46B 0 2.16B 2B 1.84B 3.46B 238B 3.52B 23.87B 9.36B 116B 9.25B 9.05B 400B |
| Net Debt | 11.18B 0 9.8B 9.06B 8.33B 15.72B 1,078B 15.98B 108B 42.47B 528B 41.99B 41.08B 1,818B | 8.44B 0 7.39B 6.83B 6.29B 11.86B 813B 12.05B 81.72B 32.03B 398B 31.68B 30.98B 1,371B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | ILA 9,642.00 | -0.96% | 759,073 |
| 17/07/26 | ILA 9,735.00 | -0.41% | 485,235 |
| 16/07/26 | ILA 9,775.00 | +2.57% | 1,284,861 |
| 15/07/26 | ILA 9,530.00 | -0.16% | 599,684 |
| 14/07/26 | ILA 9,545.00 | -3.00% | 991,824 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
